SNORA71A Promotes Colorectal Cancer Cell Proliferation, Migration, and Invasion

Zhengxiang Zhang1, Yunxiang Tao2, Qingling Hua1

  • 1Department of Oncology, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China.

Insights

Small nucleolar RNAs (snoRNAs) are key in colorectal cancer (CRC). SNORA71A, a specific snoRNA, is upregulated in CRC and promotes tumor growth and spread, acting as an oncogene.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genomics

Background:

  • Small nucleolar RNAs (snoRNAs) are implicated in colorectal cancer (CRC) pathogenesis.
  • The specific role of SNORA71A in CRC remains largely unexplored.
  • Identifying novel biomarkers and therapeutic targets in CRC is crucial.

Purpose of the Study:

  • To screen for differentially expressed snoRNAs in colorectal cancer (CRC) tissues.
  • To investigate the functional role of the identified key snoRNA, SNORA71A, in CRC.
  • To assess SNORA71A as a potential biomarker and oncogene in CRC.

Main Methods:

  • Small RNA sequencing was employed to analyze snoRNA expression profiles in CRC and normal tissues.
  • Quantitative PCR (qPCR) and Cancer Genome Atlas (TCGA) data were used for expression validation.
  • Cell proliferation, migration, and invasion assays (CCK8, Transwell) were performed to determine SNORA71A's function.

Main Results:

  • 107 significantly differentially expressed snoRNAs were identified in CRC, with 45 upregulated and 62 downregulated.
  • SNORA71A was found to be significantly upregulated in CRC tissues and cells, correlating with TNM stage and lymph node metastasis.
  • Overexpression of SNORA71A promoted CRC cell proliferation, migration, and invasion in vitro.

Conclusions:

  • SNORA71A functions as an oncogene in colorectal cancer (CRC).
  • Upregulated SNORA71A expression facilitates CRC cell proliferation, migration, and invasion.
  • SNORA71A holds potential as a diagnostic biomarker and therapeutic target for CRC.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.6K